| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Short Communication |
1 Northern California Cancer Center, Fremont, California and 2 Comprehensive Cancer Center, Wake Forest University, Winston-Salem, North Carolina
Requests for reprints: Esther M. John, Northern California Cancer Center, 2201 Walnut Avenue, Suite 300, Fremont, CA 94538. Phone: 510-608-5007; Fax: 510-608-5085. E-mail: ejohn{at}nccc.org
Mounting experimental and epidemiologic evidence supports the hypothesis that vitamin D reduces the risk of prostate cancer. Some evidence suggests that prostate cancer risk may be influenced by sun exposure early in life. We analyzed data from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study to examine associations of prostate cancer risk with early-life and adult residential sun exposure and adult sun exposures that were assessed through self-report, physician report, and dermatologic examination. We used solar radiation in the state of birth as a measure of sun exposure in early life. Follow-up from 1971 to 1975 (baseline) to 1992 identified 161 prostate cancer cases (102 nonfatal and 59 fatal) among non-Hispanic white men for whom sun exposure data were available. Significant inverse associations were found for men born in a region of high solar radiation (relative risk, 0.49, 95% confidence interval, 0.27-0.90 for high versus low solar radiation), with a slightly greater reduction for fatal than for nonfatal prostate cancer. Frequent recreational sun exposure in adulthood was associated with a significantly reduced risk of fatal prostate cancer only (relative risk, 0.47; 95% confidence interval, 0.23-0.99). These findings suggest that, in addition to sun exposure in adulthood, sun exposure in early life protects against prostate cancer. (Cancer Epidemiol Biomarkers Prev 2007;16(6):1283–6)
This article has been cited by other articles:
|
|
 |
|
  J. N. P. Rohan and N. L. Weigel 1{alpha},25-Dihydroxyvitamin D3 Reduces c-Myc Expression, Inhibiting Proliferation and Causing G1 Accumulation in C4-2 Prostate Cancer Cells Endocrinology, May 1, 2009; 150(5): 2046 - 2054. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Millen, M. Pettinger, J. L. Freudenheim, R. D. Langer, C. A. Rosenberg, Y. Mossavar-Rahmani, C. M. Duffy, D. S. Lane, A. McTiernan, L. H. Kuller, et al. Incident Invasive Breast Cancer, Geographic Location of Residence, and Reported Average Time Spent Outside Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 495 - 507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-L. Yu, Y. Li, D. M. Freedman, T. R. Fears, R. Kwok, G. Chodick, B. Alexander, M. G. Kimlin, A. Kricker, B. K. Armstrong, et al. Assessment of Lifetime Cumulative Sun Exposure Using a Self-Administered Questionnaire: Reliability of Two Approaches Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 464 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. Lieben, C. Mathieu, and M. Demay Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice Endocr. Rev., October 1, 2008; 29(6): 726 - 776. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. B. Grant Re: Prospective Study of Vitamin D and Cancer Mortality in the United States J Natl Cancer Inst, June 4, 2008; 100(11): 826 - 826. [Full Text] [PDF]
|
|
|
|
 |
|
 A. E Millen and L. M Bodnar Vitamin D assessment in population-based studies: a review of the issues Am. J. Clinical Nutrition, April 1, 2008; 87(4): 1102S - 1105S. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
